Seongnam

Running trials

• Recruiting

  Futibatinib (TAS-120) in Patients With Advanced Biliary Tract Cancer

  NCT07710885· Phase 3· Source

• Recruiting

  Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

  NCT07011719· Phase 3· Source

• Recruiting

  Imjudo & Imfinzi PMS

  NCT06544629· Source

• Active, not recruiting

  Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

  NCT06608927· Phase 3· Source

• Active, not recruiting

  Volrustomig Priming Regimens Exploratory Phase II Platform Study

  NCT06448754· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Liver and biliary tract cancer2 recruiting
• Childhood cancers1 recruiting
• Kidney cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body

  NCT05568095· Phase 3· Source

• Completed

  QTERN (SAXAGLIPTIN/DAPAGLIFLOZIN FDC) Regulatory Post-Marketing Surveillance

  NCT05160974· Source

• Completed

  'OLAP' (OLAparib Regulatory Post-marketing Surveillance)

  NCT04553926· Source